Psychopharmacology: A Master Class 2025

Monday, February 24, 2025, 9:00 AM - Friday, February 28, 2025, 12:00 PM, Miami Grand Beach Hotel, Miami, FL


AMA PRA Category 1 Credits™ (15.00 hours), APA Credit(s) (15.00 hours), Non-Physician Attendance (15.00 hours)

This seminar will begin with an updated review of modern neurobiology ranging from genomics, epigenetics and neurotransmitters systems to brain circuitry and imaging. The seminal role of child abuse and neglect in increased vulnerability to mood and anxiety disorders will be explored with a focus on the long-term persistent effects of early life trauma on the brain and the body. An update on the pathophysiology of the major mood and anxiety disorders will be described including new data on inflammation. The latest data on suicide will be presented including risk factors and strategies for prevention. 

Treatment of  depression, anxiety, and women’s psychiatric disorders will be described. The evidence-based effectiveness of antipsychotic medications will be emphasized? as augmenting agents in major depression. Newer agents such as brexanolone, bupropion-dextromethorphan combination and augmenting medications including pramipexole for the treatment of mood disorders will be discussed with an emphasis on treatment-resistant depression including bipolar depression. Medications in development will also be described The benefits and risks of ketamine and esketamine will be explored as well as the uses of ECT and TMS.   A comprehensive review of  depression comorbid with medical illnesses will be highlighted, particularly the role of depression in cancer and cardiovascular illness and the necessity for treatment. 

The neurobiological mechanisms of anxiety and anxiety-spectrum disorders (including GAD, OCD, and panic disorders) as well as their treatment will be reviewed with special emphasis on management of treatment resistant post-traumatic stress disorder (PTSD). Advances in personalized or precision medicine will be a major focus of the course including both pharmacotherapy and psychotherapy. The controversy concerning the use of pharmacogenomic tests to predict antidepressant treatment response will be discussed in detail. Finally the burgeoning area of psychedelic medicine in psychiatry will be comprehensively reviewed.  
The seminar will emphasize the establishment and importance of the therapeutic alliance when prescribing all psychotropic medications. 

1. Apply the latest advances in the neurobiology of psychiatric disorders and understand the potential role of pharmacogenomic testing in the selection of specific psychiatric medications.
2. Evaluate treatment options for treatment resistant bipolar and unipolar depression including psychotherapies.
3. Assess the neurobiological mechanism and evidence-based treatment of depressive and anxiety spectrum disorders including PTSD.
4. Determine when to implement switch versus augmentation strategies for treatment resistant depression.
5. Analyze the use of ketamine with benefits and hazards in treatment resistant depression.
6. Demonstrate when to use ECT and TMS for the treatment of depression.
7. Recognize the role of psychiatric medications during a woman’s life cycle: pregnancy, delivery, post-partum, nursing and menopause.
8. Analyze the role of psychopharmacology and psychotherapy in the treatment of PTSD.
9. Assess the current data base on the efficacy and side effect profile of psychedelic medications.

1. Evaluate treatment options for treatment resistant bipolar and unipolar depression including psychotherapies.
2. Assess the neurobiological mechanism and evidence-based treatment of depressive and anxiety spectrum disorders including PTSD.
3. Apply the latest advances in the neurobiology of psychiatric disorders and understand the potential role of pharmacogenomic testing in the selection of specific psychiatric medications.
4. Determine when to implement switch versus augmentation strategies for treatment resistant depression.
5. Analyze the use of ketamine with benefits and hazards in treatment resistant depression.
6. Demonstrate when to use ECT and TMS for the treatment of depression.
7. Recognize the role of psychiatric medications during a woman’s life cycle: pregnancy, delivery, post-partum, nursing and menopause.
8. Analyze the role of psychopharmacology and psychotherapy in the treatment of PTSD.
9. Assess the current data base on the efficacy and side effect profile of psychedelic medications.

SEMINAR FORMAT
Meets Monday-Friday: 9:00 a.m.- 12:15 p.m.

Please note coffee is available during registration, and a healthy, delectable continental breakfast will be served at 10:15 a.m. daily.


SPECIAL REQUESTS
If special arrangements are required for an individual to attend this conference, contact Kim Miele at [email protected] at least 15 days before the conference.

TUITION
Physician, Nurse Practitioner, and Other Health Professional fees:
Early bird pricing is $995; after 12/16/24, registration is $1,095.

Residents, Fellows in Training, and Full-time Student fees are $695
To register: https://umiami-cme.org/

The fee for attending a second week is $750, and the processing fee (non-refundable) is $10 for all course registrations. Registration by credit card (Visa, MasterCard, or American Express) or check can be made through the University of Miami secure registration system.

REFUND POLICY
Refunds, less an administrative fee of $100, will be issued for all cancellations received two weeks before the start of the course. Refund requests must be received by email. No refund will be issued should cancellation occur less than two weeks prior. “No shows” are subject to the full course fee, and no refunds will be issued once the conference has started.


ELECTRONIC SYLLABUS
We provide all attendees with completely free access to all slide presentations in digital PDF format before the conference. This is an environmentally friendly alternative that helps lower costs for all attendees. The e-syllabus will be available for 30 days after the conference. For all winter seminars, you can purchase a printed copy at the time of online registration for $55.

Please note we will not have hard copies of the syllabus available for purchase at the conference.

 

The University of Miami Leonard M. Miller School of Medicine designates this Live Activity for a maximum of 15.00 of AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Miami Grand Beach Hotel
4835 Collins Avenue
Miami Beach, FL
The Grand Beach Hotel Miami Beach, Florida, is in an amazing location overlooking more than 200 feet of beautiful white sandy tropical beaches on the Atlantic Ocean. Built-in 2009 and completely renovated in 2018, our modern Miami Hotel offers the highest levels of luxury and comfort. Our leisure facilities include two hot tubs, a state-of-the-art gym with unbeatable panoramic sunset views, as well as three different swimming pools, including two beach-level family pools and our top-floor tranquility pool (adults only), offering something for every guest.
Miami Grand Beach Hotel, 4835 Collins Avenue, Miami Beach, FL 33140 
To reserve your hotel room, click: 
Link to register:  HTML Link: https://be.synxis.com/?Hotel=77298&Chain=16961&arrive=2025-02-21&depart=2025-03-15&adult=2&child=0&group=2502UMPSY
Group code:  2502UMPSY

Kim Miele, Course Director
Director, Continuing Education
University of Miami, Miller School of Medicine

Mitigation of Relevant Financial Relationships

The University of Miami adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.